Ahmed Dahmani
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 3
- MicroRNA in disease regulation 2
-
- Chromatin Remodeling and Cancer 3
- PI3K/AKT/mTOR signaling in cancer 2
- Ophthalmology top 10%
-
- Cancer Treatment and Pharmacology 3
- Peptidase Inhibition and Analysis 3
- Cancer Cells and Metastasis 2
- Biophysics top 10%
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Elisabetta MarangoniFariba NématiCéline VallotJustine MarsolierKevin GrosselinAdeline DurandFabien ReyalMarcel Reichen
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Ahmed Dahmani
20 papers receiving 671 citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Cancer Research 160
- Molecular Biology 469
- Ophthalmology 60
- Oncology 133
- Biophysics 24
Countries citing papers authored by Ahmed Dahmani
This map shows the geographic impact of Ahmed Dahmani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed Dahmani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed Dahmani more than expected).
Fields of papers citing papers by Ahmed Dahmani
This network shows the impact of papers produced by Ahmed Dahmani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed Dahmani. The network helps show where Ahmed Dahmani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ahmed Dahmani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 80 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 17 | |
| 11 | 2022 | 1 | |
| 12 | 2021 | 17 | |
| 13 | 2021 | 25 | |
| 14 | 2021 | 12 | |
| 15 | High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancerbreakdown → | 2019 | 329 |
| 16 | 2016 | 50 | |
| 17 | 2016 | 36 | |
| 18 | 2014 | 20 | |
| 19 | 2010 | 2 | |
| 20 | L'Algérie à l'épreuve : économie politique des réformes 1980-1997 | 1999 | 5 |
About Ahmed Dahmani
Ahmed Dahmani is a scholar working on Cancer Research, Oncology and Toxicology, having authored 22 papers that have together received 681 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (3 papers), Chromatin Remodeling and Cancer (3 papers), Cancer Treatment and Pharmacology (3 papers), Peptidase Inhibition and Analysis (3 papers), Cancer Genomics and Diagnostics (3 papers), MicroRNA in disease regulation (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (160 citations), Molecular Biology (469 citations) and Ophthalmology (60 citations). Ahmed Dahmani has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Elisabetta Marangoni, Fariba Némati, Céline Vallot, Justine Marsolier, Kevin Grosselin, Adeline Durand, Fabien Reyal, Marcel Reichen, Colin J. H. Brenan and Andrew D. Griffiths. Their work appears in journals such as Nature Genetics, Development and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.